Key Takeaways:
Align Technology Inc. (Nasdaq: ALGN) will invest approximately $200 million to open a new manufacturing facility in Hyderabad, India, expanding its global production network to meet growing demand in the Asia-Pacific region. The plant, expected to open in 2027, will create more than 300 jobs and represents the company's first manufacturing site in India.
"India represents an important growth market for Align, and we are excited about the opportunity to expand our global manufacturing network with a new facility in Hyderabad," said Jitse Marrée, Align executive vice president, global operations. "This investment underscores our commitment to scaling our advanced manufacturing capabilities, supporting our doctor customers, and bringing the benefits of the Invisalign® System to more patients worldwide."
The new facility will be Align's fourth globally and is designed to be margin accretive within its first year of operation. It complements the company's existing Global Capability Center and Align Innovation Center, both located in Hyderabad, reinforcing the city's role as a strategic hub for the company. The capital and operational expenses for the project were included within the company's 2026 capital equipment guidance.
This expansion is a key part of Align's strategy to localize its supply chain and better serve the high-growth Asia-Pacific market. By manufacturing its Invisalign clear aligners closer to its customers, the company aims to enhance service levels, improve operational efficiency, and strengthen its supply chain. The move is supported by Align's strong balance sheet, which reports more cash than debt.
The Hyderabad plant is a significant step in Align's long-term commitment to the Asia-Pacific region, building on previous investments in local teams and digital treatment planning infrastructure. The facility will produce the company's flagship Invisalign clear aligners, a teeth-straightening solution that uses a series of custom-made, removable plastic trays.
"The Hyderabad facility represents an important milestone as we scale our operations in high-growth markets and further strengthen our ability to support Invisalign-trained doctors and their patients," said JunHo Han, Align executive vice president and managing director for Asia Pacific. The company also manufactures iTero intraoral scanners and exocad CAD/CAM software, which are used in digital orthodontics and restorative dentistry.
The investment follows a strong financial performance, with Align Technology reporting first-quarter 2026 earnings that surpassed analyst expectations. The company posted an EPS of $2.58 on revenue of $1.04 billion, beating forecasts of $2.30 and $1.02 billion, respectively. The new facility, which is expected to be margin-accretive in its first year, signals a move to deploy capital for long-term growth. Some market analysis suggests the company's stock may be undervalued, and this strategic expansion into a key growth market could be a factor for investors to watch.
This article is for informational purposes only and does not constitute investment advice.
